1 / 1

Cipla looks to invest more in mRNA tech - holds discussions with firms

Cipla looks to invest more in mRNA tech - holds discussions with firms

AaliyaGoyel
Télécharger la présentation

Cipla looks to invest more in mRNA tech - holds discussions with firms

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Downloaded from: justpaste.it/7ga6d Cipla looks to invest more in mRNA tech; holds discussions with firms Speaking to Business Standard, Samina Hamied, executive vice chairperson, Cipla, says one must invest in research and development (R&D) to feed the commercial growth engines After taking the lead in having a strong Covid-19 portfolio during the pandemic, Cipla is now gearing up for the next stage of growth in terms of innovation and expanding its presence in newer domains. The Mumbai-based firm has held discussions with mRNA technology companies over the last eight months as it looks to invest in a few of them. “We have been talking to mRNA technology owners in the past eight months. We are at a stage when we might invest in a few mRNA companies. The best way is to invest in such technology companies and then grow them in- house,” said Umang …

More Related